For patients with existing heart disease, semaglutide's proven CV benefit is a major differentiator
Were thrilled to introduce GLP-1 as part of our comprehensive approach to weight management
One recent study found that GLP-1RAs may help lower the risk for depression compared to another medication for diabetes treatment, dipeptidyl peptidase-4 inhibitors
Roslan J, Giribabu N, Karim K, Salleh N
Powered by Froala Editor Drug Interactions Ozempic (semaglutide) may interact with other drugs, altering effectiveness or increasing side effects
Common experiences: Nausea limited to occasional mornings or specific triggers Normal energy levels returning Established appetite suppression without discomfort Visible weight loss becoming apparent Weight loss: Typically 12-15% cumulative by end of month 3 Management priority: Transition to sustainable eating patterns